GREGOIRE DANIEL N 4

4 · MAGELLAN HEALTH INC · Filed Mar 6, 2018

Form 4

Period: 2018-03-05

General Counsel and Secretary

Transactions

Exercise of In-Money
Ordinary Common Stock, $0.01 par value
2018-03-05$63.95/sh+12,538$801,805→ 25,995 total
Exercise of In-Money
Ordinary Common Stock, $0.01 par value
2018-03-05$64.87/sh+5,042$327,075→ 31,037 total
Exercise of In-Money
Ordinary Common Stock, $0.01 par value
2018-03-05$68.50/sh+5,295$362,708→ 36,332 total
Sale
Ordinary Common Stock, $0.01 par value
2018-03-05$99.05/sh−22,875$2,265,698→ 13,457 total
Exercise of In-Money
Stock Options (right to buy)
2018-03-05−12,538→ 0 total
Exercise: $63.95Exp: 2025-03-04→ Common Stock (12,538 underlying)
Exercise of In-Money
Stock Options (right to buy)
2018-03-05−5,042→ 5,041 total
Exercise: $64.87Exp: 2026-03-03→ Common Stock (5,042 underlying)
Exercise of In-Money
Stock Options (right to buy)
2018-03-05−5,295→ 10,590 total
Exercise: $68.50Exp: 2027-03-03→ Common Stock (5,295 underlying)

Footnotes (6)

[F1]This transaction was effectuated pursuant to a Rule 10b-5-1 Plan.
[F2]The number of securities reported represents an aggregate number of shares sold in multiple open market transactions at prices ranging from $98.75 to $99.25, inclusive. The price reported represents the weighted average price. The Reporting Person undertakes to provide staff of the SEC, the issuer, or a stockholder of the issuer, upon request, the number of shares sold by the Reporting Person at each separate price within the range.
[F3]All of the stock options in this tranche have vested in full.
[F4]Not applicable.
[F5]The remainder of 5,041 options shall vest on March 3, 2019.
[F6]The remainder of 10,590 options shall vest in equal increments on each of March 3 of 2019 and 2020.

Documents

1 file